Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge

Kaikai Wang1, Junjie Wang2, Jiahao Zhang1

  • 1Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Frontiers in Oncology
|July 14, 2022
PubMed

Insights

Ferroptosis, a novel cell death, is crucial for understanding and overcoming glioma

Area of Science:

  • Oncology
  • Immunology
  • Cell Death Research

Background:

  • Glioma is a prevalent adult brain tumor with poor prognosis.
  • Current treatments, including Stupp protocol, offer limited survival benefits.
  • Immunotherapy efficacy in glioma is hindered by the tumor's immunosuppressive microenvironment.

Purpose of the Study:

  • To review the role of ferroptosis in the glioma immune microenvironment.
  • To explore strategies for remodeling the immunosuppressive microenvironment to enhance glioma immunotherapy.
  • To highlight the crosstalk between ferroptosis and the tumor immune microenvironment.

Main Methods:

  • Literature review of recent studies on ferroptosis and glioma.
  • Analysis of the mechanisms underlying ferroptosis in the context of the glioma immune microenvironment.
  • Synthesis of information on the interplay between ferroptosis and immune cells within gliomas.

Main Results:

  • Ferroptosis, a distinct form of regulated cell death, significantly impacts tumor progression.
  • The glioma immune microenvironment contributes to immunotherapy resistance.
  • Emerging evidence indicates a critical role for ferroptosis in modulating this microenvironment.

Conclusions:

  • Ferroptosis is a key factor in the glioma immune microenvironment.
  • Targeting ferroptosis presents a promising strategy to overcome glioma immunotherapy resistance.
  • Further research into ferroptosis is essential for developing effective glioma treatments.

Related Concept Videos